Elderly AML patients with risk of anthracycline toxicity
Showing 1 - 25 of >10,000
Newly Diagnosed Secondary or High Risk AML Trial in Spain (CPX-351)
Active, not recruiting
- Newly Diagnosed Secondary or High Risk AML
-
Badalona, Spain
- +11 more
Jul 9, 2021
Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Decitabine for Injection
- VENCLYXTO
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023
Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Standard Intervention
- Investigational Intervention
- (no location specified)
Aug 8, 2023
Acute Myeloid Leukemia, Adult, Cardiotoxicity, Endothelial Dysfunction Trial in Samara (History taking, Anthropometry, Complete
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- History taking
- +14 more
-
Samara, Samara Region, Russian FederationClinics of the Samara Medical University
Jan 26, 2023
Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive
Unknown status
- Acute Myeloid Leukemia, in Relapsed or Refractory
- +2 more
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 8, 2020
Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- standard combination chemotherapy
- decitabine
-
Edegem, Antwerpen, Belgium
- +52 more
Sep 13, 2022
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (Azacitidine, Durvalumab)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Azacitidine
- Durvalumab
-
New Haven, Connecticut
- +94 more
Jun 9, 2022
Chemotherapy Toxicity and Survival in Elderly Cancer CARG Score
Not yet recruiting
- Solid Tumors ,Adults
- calculating CARG score
- (no location specified)
Jul 18, 2022
Acute Myeloid Leukemia, Adult Trial in Suzhou (venetoclax combined with decitabine)
Unknown status
- Acute Myeloid Leukemia, Adult
- venetoclax combined with decitabine
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Nov 8, 2021
Cardiotoxicity, Childhood Cancer Trial in Montpellier (cardiac ultrasound with speckle tracking analysis)
Recruiting
- Cardiotoxicity
- Childhood Cancer
- cardiac ultrasound with speckle tracking analysis
-
Montpellier, FrancePediatric and Congenital Cardiology and Pulmonology Department,
Mar 23, 2023
Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +3 more
Nov 21, 2023
Acute Myeloid Leukemia Trial in Italy (Venetoclax and Decitabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax and Decitabine
-
San Giovanni Rotondo, Foggia, Italy
- +24 more
Aug 8, 2022
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 1, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Acute Myeloid Leukemia Trial in Copenhagen (Venetoclax)
Recruiting
- Acute Myeloid Leukemia
-
Copenhagen, DenmarkDepartment of Hematology, Rigshospitalet
Jun 21, 2022
Acute Myeloid Leukemia Trial in Kunming (Venetoclax in Combination With Azacitidine and HA Regimen)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax in Combination With Azacitidine and HA Regimen
-
Kunming, Yunnan, ChinaThe Second Affiliated Hospital of Kunming Medical University.
Jul 10, 2023
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Gemtuzumab Ozogamicin
-
Valhalla, New YorkNew York Medical College
Sep 26, 2022
Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)
Recruiting
- Acute Myeloid Leukemia, Adult
- ADI-PEG 20
-
Houston, TexasMD Anderson Cancer Center
Sep 29, 2022
Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)
Recruiting
- Advanced Soft-tissue Sarcoma
- Metastatic Soft-tissue Sarcoma
-
Toulouse, FranceInstitut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022
Macular Degeneration, Age Related, Cataract Trial (NGenuity)
Not yet recruiting
- Macular Degeneration, Age Related
- Cataract
- NGenuity
- (no location specified)
Aug 3, 2023
MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Sabatolimab
- +2 more
- (no location specified)
Sep 2, 2022